Quantcast

Latest Clinical trial Stories

2014-05-01 08:35:53

CRANBURY, N.J., May 1, 2014 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential, announced that a potential commercial partner has exercised its option for an exclusive license to bremelanotide for female sexual dysfunction (FSD) indications in the European Union and other European countries. The...

2014-05-01 08:31:31

NEW YORK, May 1, 2014 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP) announced that the data from its multi-institutional post-approval trial of MuGard(®) that was recently published in Cancer, has been selected as a cover article in the premier publication. Cancer, the journal of the American Cancer Society is one of the oldest peer-reviewed journals in oncology. The publication, entitled "Multi-Institutional, Randomized, Double-Blind, Placebo-Controlled Trial to Assess...

2014-04-30 16:30:20

Conference call to be held on Wednesday, April 30, 2014 at 4:30 p.m. Eastern Time BOTHELL, Wash. and VANCOUVER, British Columbia, April 30, 2014 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today provided a summary of clinical developments and anticipated near-term milestones and announced first quarter 2014 financial results. Clinical Developments and Anticipated Near-term Milestones -- Custirsen -- Top-line survival results announced on April 28, 2014...

2014-04-30 16:29:48

DUBLIN, April 30, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/d4v9vs/clinical_trial) have announced the addition of the "Clinical Trial Management System Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2019" [http://www.researchandmarkets.com/research/d4v9vs/clinical_trial ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Clinical trial management...

2014-04-30 08:34:12

LEXINGTON, Massachusetts, April 30, 2014 /PRNewswire/ -- - OPUS-2, a Phase 3 placebo-controlled study of lifitegrast 5.0%; results presented at the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting in Boston - SONATA, a Phase 3 placebo-controlled, long-term (one-year) safety study of lifitegrast 5.0%; top-line results announced Shire plc (LSE: SHP, NASDAQ: SHPG), the global specialty...

2014-04-30 08:33:57

Positive Clinician-Reported Patient Assessments Consistent with Earlier Findings Reported with ADS-5102 EMERYVILLE, Calif., April 30, 2014 /PRNewswire/ -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a specialty pharmaceutical company, today presented data on the safety and efficacy of ADS-5102 for the treatment of levodopa-induced dyskinesia (LID), a serious movement disorder associated with Parkinson's disease treatment. The data, from Adamas' Phase 2/3 EASED study, included...

2014-04-30 08:33:40

Grant Supports Steps Towards Investigational New Drug Filing and Clinical Trials SEATTLE, April 30, 2014 /PRNewswire/ -- Oricula Therapeutics, LLC, a biotech company uniquely positioned to introduce medicines to preserve hearing, announced that it has received a grant of $169,398 through the Small Business Innovation Research Program by the National Institute on Deafness and Other Communication Disorders of the National Institutes of Health. The award supports preclinical studies to...

2014-04-30 08:31:35

ACRP Innovation Award is Latest for CRO Health Decisions DURHAM, N.C., April 30, 2014 /PRNewswire-iReach/ -- Health Decisions, Inc., the full-service clinical research organization of choice for forward-looking biopharma and medical devices companies, today announced that the Association of Clinical Research Professionals (ACRP) honored CEO Michael Rosenberg, MD, MPH, with its 2014 Innovation in Clinical Research Award at the ACRP Global Conference in San Antonio April 26. Photo -...

2014-04-29 16:30:53

Dr John Hong joins WCCT Global as Leading Private Investigator for Gastroenterology Clinical Trials COSTA MESA, Calif., April 29, 2014 /PRNewswire-iReach/ -- Today, WCCT Global announced that Dr. John Hong has joined the organization as the Head of GI Clinical Research. John Hong, MD, MBA brings many years of GI Clinical Care and Research experience to the role. He is a graduate of the University Of Miami School Of Medicine and completed his Internal Medicine Residency and...

2014-04-29 12:33:17

Theorem Selects iMedNet(TM) EDC as Their eClinical Solution of Choice for Medical Device & Diagnostics Research Initiatives MINNETONKA, Minn., April 29, 2014 /PRNewswire/ -- MedNet Solutions, a global life sciences technology company specializing in eClinical technology systems, is pleased to welcome Theorem Clinical Research into the iMedNet Partner Program. Theorem, one of the industry's leading contract research organizations, provides comprehensive clinical research and development...


Word of the Day
attercop
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'
Related